Quarterly report pursuant to Section 13 or 15(d)

Liquidity and Financial Condition (Details Narrative)

v3.23.3
Liquidity and Financial Condition (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Line of Credit Facility [Line Items]              
Working capital deficit $ 41,500,000   $ 41,500,000        
Stockholders' deficit 27,559,424   27,559,424   $ 29,094,588    
Net income (loss) (548,229) $ (1,341,561) 1,535,164 $ (4,112,913) (334,989,282)    
Net income (loss) 548,229 1,341,561 (1,535,164) 4,112,913 334,989,282    
Revenue 3,500,000 $ 2,800,000 14,800,000 $ 7,600,000      
Accrued expenses 6,720,113   6,720,113   5,736,096    
Public Health and Social Services Emergency Fund [Member]              
Line of Credit Facility [Line Items]              
Relief funds     100,000,000,000        
HHS Provider Relief Funds [Member]              
Line of Credit Facility [Line Items]              
Relief funds     13,600,000        
Revenue 13,300,000   300,000        
Revenue recognized         $ 600,000 $ 4,400,000 $ 8,000,000.0
Accrued expenses $ 300,000   300,000        
Revenue recognized, liability     $ 13,300,000